PCN129 A COST-UTILITY AND BUDGET IMPACT ANALYSIS OF ENZALUTAMIDE FOR THE TREATMENT OF NONMETASTATIC CASTRATION-RESISTANT PROSTATE CANCER (NMCRPC) IN MEXICO
2020 ◽
Vol 23
◽
pp. S45-S46
W. Toro
◽
S. Braun
◽
L.A. Sanchez
◽
P. Anaya
Ken O'Day
◽
Cat N. Bui
◽
Scott Flanders
◽
Nina Oestreicher
◽
Peter Francis
◽
...
2013 ◽
Vol 16
(7)
◽
pp. A394
T. Li
◽
M. Thompson
◽
M. Todd
◽
M. Yu
◽
T. Kheoh
◽
...
CD Mullins
◽
H Le
◽
J Lawson
◽
F Pan
2015 ◽
Vol 18
(7)
◽
pp. A442
S Di Matteo
◽
MC Valentino
◽
GM Bruno
◽
GL Colombo
JG Gay
◽
NM Schultz
◽
S Braun
Sreevalsa Appukkuttan
◽
Ryan Farej
◽
LaStella Miles
◽
Molly Purser
◽
Lonnie Wen
2015 ◽
Vol 18
(3)
◽
pp. A196
C.N. Bui
◽
K. O’Day
◽
S. Flanders
◽
N. Oestreicher
◽
P. Francis
◽
...
2014 ◽
Vol 17
(7)
◽
pp. A622
2013 ◽
Vol 16
(7)
◽
pp. A665
◽
V. Vitale
◽
E. Asano
◽
M.L. Pereira
Close
Export Citation Format
Close
Share Document
Close